GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
2.060
-0.140 (-6.36%)
At close: May 22, 2026, 4:00 PM EDT
2.050
-0.010 (-0.49%)
After-hours: May 22, 2026, 7:51 PM EDT

GRI Bio Stock Forecast

GRI's stock price has decreased by -94.67% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 2 analysts polled by S&P Global, GRI Bio stock has a consensus rating of "Strong Buy" and an average price target of $25. The average 1-year stock price forecast is 1,113.59% higher than the current stock price, while the lowest is $10 (+385.44%) and the highest is $40 (+1,841.75%).

Price Target: $25 (+1,113.59%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$10$25$25$40
Change+385.44%+1113.6%+1113.6%+1841.7%
* Price targets were last updated on Mar 11, 2026.

Analyst Ratings

The average analyst rating for GRI Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy222222
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total222222

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Ascendiant Capital
Ascendiant Capital
Strong Buy
Maintains
$1,008$40
Strong BuyMaintains$1,008$40+1,841.75%Mar 11, 2026
Ascendiant Capital
Ascendiant Capital
Strong Buy
Maintains
$980$1,008
Strong BuyMaintains$980$1,008+48,832.04%Dec 8, 2025
Ascendiant Capital
Ascendiant Capital
Strong Buy
Maintains
$952$980
Strong BuyMaintains$952$980+47,472.82%Sep 22, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$280
Strong BuyReiterates$280+13,492.23%Jun 11, 2025
Ascendiant Capital
Ascendiant Capital
Strong Buy
Maintains
$1,120$952
Strong BuyMaintains$1,120$952+46,113.59%May 27, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.52
from -121.80
EPS Next Year
-21.92
from -3.52
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
-------
Revenue Growth
-------
EPS
-----121.80-3.52-21.92
EPS Growth
-------
Forward PE
-------
No. Analysts
-----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202620272028
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth202620272028
High--
Avg--
Low--

EPS Forecast

EPS202620272028
High-0.92-5.68
Avg-3.52-21.92
Low-5.98-37.24

EPS Growth

EPS Growth202620272028
High--
Avg--
Low--
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.